Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William A Stokes

Showing results (61-70 of 81) with videos related to

Pageof 9
Sort By:
Cancers|December 11, 2022
Current Radiotherapy Considerations for Nasopharyngeal CarcinomaWai Tong Ng, James C H Chow, Jonathan J Beitler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2018
Post-Treatment Mortality After Surgery and Stereotactic Body Radiotherapy for Early-Stage Non-Small-Cell Lung CancerWilliam A Stokes, Michael R Bronsert, Robert A Meguid, et al.
Clinical Lung Cancer|March 29, 2024
Lung Cancer Survival Trends in the Veterans Health AdministrationDrew Moghanaki, James Taylor, Alex K Bryant, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 23, 2022
Impact of radiation dose to the immune cells in unresectable or stage III non-small cell lung cancer in the durvalumab eraNeal S McCall, Hamilton S McGinnis, James R Janopaul-Naylor, et al.
Cancer|June 24, 2023
Safety and efficacy of durvalumab after concurrent chemoradiation in Black patients with locally advanced non-small cell lung cancerNeal S McCall, James R Janopaul-Naylor, H Scott McGinnis, et al.
The Laryngoscope|February 15, 2020
Outcomes and Predictive Value of Post-adjuvant Therapy PET/CT for Locally Advanced Oral Squamous Cell CarcinomaDavid C Qian, Kelly R Magliocca, Ashley H Aiken, et al.
International Journal of Radiation Oncology, Biology, Physics|December 19, 2020
Immunomodulatory Low-Dose Whole-Lung Radiation for Patients with Coronavirus Disease 2019-Related PneumoniaClayton B Hess, Tahseen H Nasti, Vishal R Dhere, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 12, 2025
Early-phase trial of IAP antagonist tolinapant and definitive radiation in cisplatin-ineligible patients with advanced head and neck cancerNicole C Schmitt, William A Stokes, James E Bates, et al.
Head & Neck|December 1, 2021
The omission of intentional primary site radiation following transoral robotic surgery in 59 patients: No local-regional failuresVishal R Dhere, Chase E Escott, Sibo Tian, et al.
Head & Neck|December 8, 2025
Minimizing Chemoradiation Using a Surgical Algorithm for HPV-Associated Cancer of Unknown PrimaryGeorges E Daoud, Andre J Burnham, Nikhil T Vettikattu, et al.
Pageof 9

Showing results (61-70 of 81) with videos related to

Sort By:
Pageof 9
Cancers|December 11, 2022
Current Radiotherapy Considerations for Nasopharyngeal CarcinomaWai Tong Ng, James C H Chow, Jonathan J Beitler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2018
Post-Treatment Mortality After Surgery and Stereotactic Body Radiotherapy for Early-Stage Non-Small-Cell Lung CancerWilliam A Stokes, Michael R Bronsert, Robert A Meguid, et al.
Clinical Lung Cancer|March 29, 2024
Lung Cancer Survival Trends in the Veterans Health AdministrationDrew Moghanaki, James Taylor, Alex K Bryant, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 23, 2022
Impact of radiation dose to the immune cells in unresectable or stage III non-small cell lung cancer in the durvalumab eraNeal S McCall, Hamilton S McGinnis, James R Janopaul-Naylor, et al.
Cancer|June 24, 2023
Safety and efficacy of durvalumab after concurrent chemoradiation in Black patients with locally advanced non-small cell lung cancerNeal S McCall, James R Janopaul-Naylor, H Scott McGinnis, et al.
The Laryngoscope|February 15, 2020
Outcomes and Predictive Value of Post-adjuvant Therapy PET/CT for Locally Advanced Oral Squamous Cell CarcinomaDavid C Qian, Kelly R Magliocca, Ashley H Aiken, et al.
International Journal of Radiation Oncology, Biology, Physics|December 19, 2020
Immunomodulatory Low-Dose Whole-Lung Radiation for Patients with Coronavirus Disease 2019-Related PneumoniaClayton B Hess, Tahseen H Nasti, Vishal R Dhere, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 12, 2025
Early-phase trial of IAP antagonist tolinapant and definitive radiation in cisplatin-ineligible patients with advanced head and neck cancerNicole C Schmitt, William A Stokes, James E Bates, et al.
Head & Neck|December 1, 2021
The omission of intentional primary site radiation following transoral robotic surgery in 59 patients: No local-regional failuresVishal R Dhere, Chase E Escott, Sibo Tian, et al.
Head & Neck|December 8, 2025
Minimizing Chemoradiation Using a Surgical Algorithm for HPV-Associated Cancer of Unknown PrimaryGeorges E Daoud, Andre J Burnham, Nikhil T Vettikattu, et al.
Pageof 9